Possible timeframes for official announcements? These are mostly guesses. I welcome any input from those of you who are much more qualified than I to speculate on this.
Apr 30 - Sign the EIB funding agreement Late May - Approval for multinational clinical trial Late June - Start of trial Sep/Oct - Results (preliminary?)
Even though compassionate use is continuing, I don't expect to hear any more details on this from the company.
This timeline seems to be in agreement with the call today.
Pluristem intends to commence Phase II studies of PLX cell therapy in the treatment of complications arising from COVID-19 as soon as it receives clearance from regulators in the U.S. and Europe. Anticipating responses in the next few weeks, Pluristem aims to complete enrollment and treatment in a few months, by utilizing its logistical and technological competitive advantages to support effective enrollment.
Market Data 
Markets 
AI
